Mabcampath 30 mg (Alemtuzumab SOLUTION) 30 MG

MABCAMPATH 30 MG is an intravenous solution containing alemtuzumab, used for specific therapeutic purposes. This medication is manufactured by Sanofi-Aventis Canada Inc. and is intended for medical use under professional guidance.

Strength

30 MG

Manufacturer / TM Owner

SANOFI-AVENTIS CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

MABCAMPATH 30 MG, containing alemtuzumab, is primarily used in the treatment of certain medical conditions. It is often prescribed for its therapeutic effects in managing specific health issues. Patients should consult their healthcare provider to understand what is MABCAMPATH 30 MG used for and how it may benefit their condition.

Side Effects

The effects of MABCAMPATH 30 MG can vary among individuals. Commonly, patients may experience a range of responses, including those related to the immune system. It is important to discuss potential effects with a healthcare professional to ensure safe and effective use.

Precautions & Warnings

Handling MABCAMPATH 30 MG requires careful consideration of safety precautions. This medication should be administered under the supervision of a healthcare provider. Patients should follow all instructions provided by their healthcare professional to minimize risks.

Avoid Interactions

MABCAMPATH 30 MG may interact with other medications or substances. It is crucial to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain other substances may also affect the efficacy and safety of this medication.

Frequently Asked Questions

MABCAMPATH 30 MG is used for specific therapeutic purposes, often related to immune system modulation. Consult your healthcare provider for detailed information.

MABCAMPATH 30 MG is administered intravenously under the supervision of a healthcare professional. Follow your healthcare provider's instructions for safe administration.

Common effects of MABCAMPATH 30 MG may include responses related to the immune system. Discuss potential effects with your healthcare provider.

Yes, precautions include following healthcare provider instructions and avoiding potential interactions with other medications or substances.

Yes, MABCAMPATH 30 MG may interact with other medications. Inform your healthcare provider about all medications you are taking to avoid potential interactions.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.